| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/03/2001 | US6255079 Polynucleotides encoding natural killer cell enhancing factor C |
| 07/03/2001 | US6255078 Nucleotide sequence which codes polypeptide associated with viral protein; for the prevention of viral infection in animals |
| 07/03/2001 | US6255076 Generating preferential protein in culture; culture genetically engineered bacteria, isolate protein form nutrients |
| 07/03/2001 | US6255075 Nucleotide sequences coding biotin holoenzyme synthetase; for the prevention and treatment of bacterial infection |
| 07/03/2001 | US6255074 Abl-interactor protein |
| 07/03/2001 | US6255073 Cell segment from drosophila; for the treatment of cancer, tumors, viral or retroviral infection and autoimmune diseases |
| 07/03/2001 | US6255072 Nucleotide sequences coding proteolytic polypeptide; for use as diagnostic tool; for the prevention of bacterial infection |
| 07/03/2001 | US6255071 Mammalian viral vectors and their uses |
| 07/03/2001 | US6255070 Generating preferential polypeptide; express nucleotide sequences which code preferential polypeptide, recover preferential polypeptide |
| 07/03/2001 | US6255068 Protein ligand; for use in the amplification of cell viability |
| 07/03/2001 | US6255067 cDNA encoding peptidyl-glycine alpha-amidating monooxygenase (PAM) |
| 07/03/2001 | US6255059 Methods for identifying G protein coupled receptor effectors |
| 07/03/2001 | US6255056 Contacting body fluid with antibody which binds analyte of specific amino acid sequence including hydroxylysyl pyridinoline or lysyl pyridinoline, detecting binding and correlating with physiological condition |
| 07/03/2001 | US6254986 Peracylating the protein or polypeptide with a cyclic anhydride having a carbon chain substituent selected from the group consisting of alkyl and alkenyl groups. |
| 07/03/2001 | US6254875 Methods for use of OMP26 from Haemophilus influenzae |
| 07/03/2001 | US6254874 Attenuated auxotrophic microorganisms having a combination of non-attenuating mutations and method for making same |
| 07/03/2001 | US6254870 Amino acid sequences |
| 07/03/2001 | US6254869 Genetic engineering, vaccines and immunoglobulins |
| 07/03/2001 | US6254863 Decreasing morbidity and mortality with infection by porphyromonas |
| 07/03/2001 | US6254862 Replication-competent adenovirus vectors |
| 07/03/2001 | US6254861 Hematopoietic growth factor derived from T lymphocytes |
| 07/03/2001 | CA2181359C Treatment of antibiotic associated diarrhea |
| 07/03/2001 | CA2078773C Gp75 as a tumor vaccine for melanoma |
| 07/03/2001 | CA2012115C Iodinated somatostatins |
| 06/28/2001 | WO2001046699A1 INHIBITION OF βARRESTIN MEDIATED EFFECTS PROLONGS AND POTENTIATES OPIOID RECEPTOR-MEDIATED ANALGESIA |
| 06/28/2001 | WO2001046698A2 Tethered ligands and methods of use |
| 06/28/2001 | WO2001046696A2 Methods and compositions for detecting hepatitis e virus |
| 06/28/2001 | WO2001046475A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046464A1 Branched compound for use in nucleic acid detection and analysis reactions |
| 06/28/2001 | WO2001046455A2 Survivin promotion of angiogenesis |
| 06/28/2001 | WO2001046454A1 P2y12 receptor |
| 06/28/2001 | WO2001046453A1 Method for extractive refolding of scrambled single-chain polypeptides |
| 06/28/2001 | WO2001046441A1 Novel polypeptide-human shc protein 43 and polynucleotide encoding it |
| 06/28/2001 | WO2001046440A1 Novel polypeptide-human neuronal thread protein 15 and polynucleotide encoding it |
| 06/28/2001 | WO2001046439A1 Novel polypeptide - human dnaj protein39 and polynucleotide encoding it |
| 06/28/2001 | WO2001046437A1 Novel polypeptide - eukaryotic rna-binding redion rnp-1-21 and polynucleotide encoding it |
| 06/28/2001 | WO2001046428A1 Vaccine strains against infection with pathogenic bacteria |
| 06/28/2001 | WO2001046423A2 Npr1-interactors and methods of use |
| 06/28/2001 | WO2001046422A1 Novel cytokine zcyto18 |
| 06/28/2001 | WO2001046421A2 Zcys5: a member of the cystatin superfamily |
| 06/28/2001 | WO2001046420A2 Il-17 and il-17r homologous polypeptides and therapeutic uses thereof |
| 06/28/2001 | WO2001046419A2 Mammalian prion proteins; related reagents and methods |
| 06/28/2001 | WO2001046418A1 Human slit polypeptide zslit3 |
| 06/28/2001 | WO2001046417A2 Human membrane proteins and polynucleotides encoding the same having homology to cd20 proteins and ige receptors |
| 06/28/2001 | WO2001046416A1 Analogs of human basic fibroblast growth factor |
| 06/28/2001 | WO2001046415A1 Novel tachykinin-like polypeptides and use thereof |
| 06/28/2001 | WO2001046414A1 Novel guanosine triphosphate-binding protein-coupled receptor protein, bg26 |
| 06/28/2001 | WO2001046413A1 Novel gene and use thereof |
| 06/28/2001 | WO2001046412A2 Interaction proteins for the stat transcription factor |
| 06/28/2001 | WO2001046411A1 A novel polypeptide, a ribosomal protein s17 10 and the polynucleotide encoding the polypeptide |
| 06/28/2001 | WO2001046410A1 A novel polypeptide- chaperone cpn60 protein 13 and the polynucleotide encoding said polypeptide |
| 06/28/2001 | WO2001046409A1 A novel polypeptide- ribosome s7 protein 9 and the polynucleotide encoding said polypeptide |
| 06/28/2001 | WO2001046408A2 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
| 06/28/2001 | WO2001046406A2 New qtl's on chromosomes x, 2, 6 and 7 of pigs |
| 06/28/2001 | WO2001046405A2 Modulation of pax-2 for controlled apoptosis or survival of cells |
| 06/28/2001 | WO2001046395A1 Multifunctional recombinant phycobiliprotein-based fluorescent constructs and phycobilisome display |
| 06/28/2001 | WO2001046390A2 Method of inactivating microorganisms |
| 06/28/2001 | WO2001046386A1 Progressive elevated gene-3 (peg-3) induces aggressive cancer phenotype and regulates angiogenesis |
| 06/28/2001 | WO2001046383A2 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
| 06/28/2001 | WO2001046262A2 Olfactory receptor genes and pseudogenes in primates and mouse |
| 06/28/2001 | WO2001046261A1 Method for treating inflammation |
| 06/28/2001 | WO2001046260A2 Novel immunoglobulin superfamily members apex-1, apex-2 and apex-3 and uses thereof |
| 06/28/2001 | WO2001046258A2 Transporters and ion channels |
| 06/28/2001 | WO2001046257A1 A novel glycoprotein hormone 11 and the polypeptide encoding thereof |
| 06/28/2001 | WO2001046256A2 Vesicle trafficking proteins |
| 06/28/2001 | WO2001046255A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046254A1 Transferrin polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046253A1 A new polypeptide-calcitonin 11 and the polynucleotide encoding it |
| 06/28/2001 | WO2001046251A1 A new polypeptide- myb protein 9 and the polynucleotide encoding it |
| 06/28/2001 | WO2001046248A1 A novel ribosomal s9 protein 26 and the polypeptide encoding thereof |
| 06/28/2001 | WO2001046245A1 A novel ribosomal protein 11 and the polypeptide encoding thereof |
| 06/28/2001 | WO2001046243A2 A new polypeptide-ring finger protein 8 and the polynucleotide encoding it |
| 06/28/2001 | WO2001046242A1 A novel sigma-54 factor 9 and the polypeptide encoding thereof |
| 06/28/2001 | WO2001046241A1 A NOVEL POLYPEPTIDE-GVPa PROTEIN 12 AND THE POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE |
| 06/28/2001 | WO2001046238A1 A novel polypeptide-homo alpha-1b-glycoprotein 12 and polynucleotide encoding said polypeptide |
| 06/28/2001 | WO2001046237A1 A novel polypeptide-homo neuronal thread protein 17 and polynucleotide encoding said polypeptide |
| 06/28/2001 | WO2001046236A1 A novel polypeptide-human sperm protein 45 and the polynucleotide encoding said polypeptide |
| 06/28/2001 | WO2001046233A1 Receptor-like protein kinases from nicotiana tabacum |
| 06/28/2001 | WO2001046232A2 Soluble interleukin-20 receptor |
| 06/28/2001 | WO2001046231A2 Polynucleotides and polypeptides encoded thereby |
| 06/28/2001 | WO2001046230A2 Kunitz domain polypeptide zkun11 |
| 06/28/2001 | WO2001046229A1 Cytokine family member, mature 2-21 |
| 06/28/2001 | WO2001046228A2 Nucleic acid vaccination |
| 06/28/2001 | WO2001046227A2 'dispatched' polypeptides |
| 06/28/2001 | WO2001046226A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 06/28/2001 | WO2001046225A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 06/28/2001 | WO2001046224A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 06/28/2001 | WO2001046223A1 Compounds and use thereof to modify transport across cell membranes |
| 06/28/2001 | WO2001046219A2 Method for production of a c1 esterase inhibitor (c1-inh)-containing composition |
| 06/28/2001 | WO2001046218A2 Fragments of pf4 and pharmaceutical compositions containing the same |
| 06/28/2001 | WO2001046217A2 Synthesis of a potent paramagnetic agonist (epm-3) of the melanocyte stimulating hormone containing amino acid-type stable free radical |
| 06/28/2001 | WO2001046214A2 Compound comprising a nucleic acid moiety and an organo-silane moiety |
| 06/28/2001 | WO2001046213A2 Compound comprising a peptide moiety and an organo-silane moiety. |
| 06/28/2001 | WO2001045748A1 Polynucleotide vaccines expressing codon optimized hiv-1 pol and modified hiv-1 pol |
| 06/28/2001 | WO2001045746A2 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 06/28/2001 | WO2001045738A2 Use of heat shock proteins to enhance production of chemokines by a cell |
| 06/28/2001 | WO2001045737A2 Herpes simplex virus-1 glycoprotein c mutants for treating unwanted hyperproliferative cell growth |
| 06/28/2001 | WO2001045730A2 Tweak receptor |
| 06/28/2001 | WO2001045728A2 Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions |
| 06/28/2001 | WO2001045639A2 Methods for protecting against lethal infection with bacillus anthracis |